S&P 500

5.475,09

0,27%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Nephros Inc (NEPH)
Nephros Inc (NEPH) Notícias

NEPH

Nephros (NEPH)

Nephros Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:NEPH

1 2 3 4 5 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
17/06/2024	18:18	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:NEPH	Nephros Inc
24/05/2024	17:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NEPH	Nephros Inc
24/05/2024	01:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:NEPH	Nephros Inc
16/05/2024	17:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEPH	Nephros Inc
10/05/2024	17:16	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:NEPH	Nephros Inc
09/05/2024	17:40	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NEPH	Nephros Inc
07/03/2024	18:15	GlobeNewswire Inc.	Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results	NASDAQ:NEPH	Nephros Inc
29/02/2024	18:30	GlobeNewswire Inc.	Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results	NASDAQ:NEPH	Nephros Inc
08/11/2023	18:15	GlobeNewswire Inc.	Nephros Announces Results for Quarter Ended September 30, 2023	NASDAQ:NEPH	Nephros Inc
03/11/2023	17:29	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:NEPH	Nephros Inc
01/11/2023	08:30	GlobeNewswire Inc.	Nephros Hires Judy Krandel as Chief Financial Officer	NASDAQ:NEPH	Nephros Inc
25/10/2023	08:30	GlobeNewswire Inc.	Nephros Schedules Third Quarter 2023 Financial Results Conference Call	NASDAQ:NEPH	Nephros Inc
09/08/2023	17:15	GlobeNewswire Inc.	Nephros Announces Results for Quarter Ended June 30, 2023	NASDAQ:NEPH	Nephros Inc
26/07/2023	08:30	GlobeNewswire Inc.	Nephros Schedules Second Quarter 2023 Financial Results Conference Call	NASDAQ:NEPH	Nephros Inc
11/05/2023	17:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NEPH	Nephros Inc
10/05/2023	17:15	GlobeNewswire Inc.	Nephros Announces Results for Quarter Ended March 31, 2023	NASDAQ:NEPH	Nephros Inc
08/05/2023	08:30	GlobeNewswire Inc.	Nephros Announces CEO Retirement and Succession Plan	NASDAQ:NEPH	Nephros Inc
28/04/2023	18:13	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:NEPH	Nephros Inc
26/04/2023	08:30	GlobeNewswire Inc.	Nephros Schedules First Quarter 2023 Financial Results Conference Call	NASDAQ:NEPH	Nephros Inc
21/04/2023	17:11	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:NEPH	Nephros Inc
21/04/2023	17:01	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:NEPH	Nephros Inc
04/04/2023	08:30	GlobeNewswire Inc.	Nephros Announces Preliminary Results for First Quarter 2023	NASDAQ:NEPH	Nephros Inc
23/03/2023	18:06	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:NEPH	Nephros Inc
08/03/2023	18:15	GlobeNewswire Inc.	Nephros Announces Fourth Quarter and Fiscal Year 2022 Financial Results	NASDAQ:NEPH	Nephros Inc
01/03/2023	18:30	GlobeNewswire Inc.	Nephros and Donastar Announce Strategic Partnership	NASDAQ:NEPH	Nephros Inc
22/02/2023	18:30	GlobeNewswire Inc.	Nephros Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call	NASDAQ:NEPH	Nephros Inc
03/02/2023	17:14	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:NEPH	Nephros Inc
11/01/2023	09:30	GlobeNewswire Inc.	Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2022	NASDAQ:NEPH	Nephros Inc
09/01/2023	18:33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NEPH	Nephros Inc
06/01/2023	14:05	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:NEPH	Nephros Inc